Acid-base  ||| S:0 E:10 ||| JJ
transport  ||| S:10 E:20 ||| NN
by  ||| S:20 E:23 ||| IN
the  ||| S:23 E:27 ||| DT
renal  ||| S:27 E:33 ||| JJ
proximal  ||| S:33 E:42 ||| NNS
tubule  ||| S:42 E:49 ||| VBP
Each  ||| S:49 E:54 ||| DT
day ||| S:54 E:57 ||| NN
,  ||| S:57 E:59 ||| ,
the  ||| S:59 E:63 ||| DT
kidneys  ||| S:63 E:71 ||| JJ
filter  ||| S:71 E:78 ||| NN
180  ||| S:78 E:82 ||| CD
L  ||| S:82 E:84 ||| NNP
of  ||| S:84 E:87 ||| IN
blood  ||| S:87 E:93 ||| NN
plasma ||| S:93 E:99 ||| NN
,  ||| S:99 E:101 ||| ,
equating  ||| S:101 E:110 ||| VBG
to  ||| S:110 E:113 ||| TO
some  ||| S:113 E:118 ||| DT
4,300  ||| S:118 E:124 ||| CD
mmol  ||| S:124 E:129 ||| NN
of  ||| S:129 E:132 ||| IN
the  ||| S:132 E:136 ||| DT
major  ||| S:136 E:142 ||| JJ
blood  ||| S:142 E:148 ||| NN
buffer ||| S:148 E:154 ||| NN
,  ||| S:154 E:156 ||| ,
bicarbonate  ||| S:156 E:168 ||| NNS
( ||| S:168 E:169 ||| -LRB-
HCO3- ||| S:169 E:174 ||| NNP
) ||| S:174 E:175 ||| -RRB-
.  ||| S:175 E:177 ||| .
The  ||| S:177 E:181 ||| DT
glomerular  ||| S:181 E:192 ||| JJ
filtrate  ||| S:192 E:201 ||| NN
enters  ||| S:201 E:208 ||| VBZ
the  ||| S:208 E:212 ||| DT
lumen  ||| S:212 E:218 ||| NN
of  ||| S:218 E:221 ||| IN
the  ||| S:221 E:225 ||| DT
proximal  ||| S:225 E:234 ||| JJ
tubule  ||| S:234 E:241 ||| NNS
( ||| S:241 E:242 ||| -LRB-
PT ||| S:242 E:244 ||| NNP
) ||| S:244 E:245 ||| -RRB-
,  ||| S:245 E:247 ||| ,
and  ||| S:247 E:251 ||| CC
the  ||| S:251 E:255 ||| DT
majority  ||| S:255 E:264 ||| NN
of  ||| S:264 E:267 ||| IN
filtered  ||| S:267 E:276 ||| JJ
HCO3-  ||| S:276 E:282 ||| NN
is  ||| S:282 E:285 ||| VBZ
reclaimed  ||| S:285 E:295 ||| VBN
along  ||| S:295 E:301 ||| IN
the  ||| S:301 E:305 ||| DT
early  ||| S:305 E:311 ||| JJ
( ||| S:311 E:312 ||| -LRB-
S1 ||| S:312 E:314 ||| NNP
)  ||| S:314 E:316 ||| -RRB-
and  ||| S:316 E:320 ||| CC
convoluted  ||| S:320 E:331 ||| NNS
( ||| S:331 E:332 ||| -LRB-
S2 ||| S:332 E:334 ||| NNP
)  ||| S:334 E:336 ||| -RRB-
portions  ||| S:336 E:345 ||| NNS
of  ||| S:345 E:348 ||| IN
the  ||| S:348 E:352 ||| DT
PT  ||| S:352 E:355 ||| NNP
in  ||| S:355 E:358 ||| IN
a  ||| S:358 E:360 ||| DT
manner  ||| S:360 E:367 ||| NN
coupled  ||| S:367 E:375 ||| VBN
to  ||| S:375 E:378 ||| TO
the  ||| S:378 E:382 ||| DT
secretion  ||| S:382 E:392 ||| NN
of  ||| S:392 E:395 ||| IN
H+  ||| S:395 E:398 ||| CD
into  ||| S:398 E:403 ||| IN
the  ||| S:403 E:407 ||| DT
lumen ||| S:407 E:412 ||| NN
.  ||| S:412 E:414 ||| .
The  ||| S:414 E:418 ||| DT
PT  ||| S:418 E:421 ||| NNP
also  ||| S:421 E:426 ||| RB
uses  ||| S:426 E:431 ||| VBZ
the  ||| S:431 E:435 ||| DT
secreted  ||| S:435 E:444 ||| JJ
H+  ||| S:444 E:447 ||| NN
to  ||| S:447 E:450 ||| TO
titrate  ||| S:450 E:458 ||| CD
non-HCO3-  ||| S:458 E:468 ||| CD
buffers  ||| S:468 E:476 ||| NN
in  ||| S:476 E:479 ||| IN
the  ||| S:479 E:483 ||| DT
lumen ||| S:483 E:488 ||| NN
,  ||| S:488 E:490 ||| ,
in  ||| S:490 E:493 ||| IN
the  ||| S:493 E:497 ||| DT
process  ||| S:497 E:505 ||| NN
creating  ||| S:505 E:514 ||| VBG
new  ||| S:514 E:518 ||| JJ
HCO3-  ||| S:518 E:524 ||| NN
for  ||| S:524 E:528 ||| IN
transport  ||| S:528 E:538 ||| NN
into  ||| S:538 E:543 ||| IN
the  ||| S:543 E:547 ||| DT
blood ||| S:547 E:552 ||| NN
.  ||| S:552 E:554 ||| .
Thus ||| S:554 E:558 ||| RB
,  ||| S:558 E:560 ||| ,
the  ||| S:560 E:564 ||| DT
PT  ||| S:564 E:567 ||| NNP
-  ||| S:567 E:569 ||| :
along  ||| S:569 E:575 ||| RB
with  ||| S:575 E:580 ||| IN
more  ||| S:580 E:585 ||| RBR
distal  ||| S:585 E:592 ||| JJ
renal  ||| S:592 E:598 ||| JJ
segments  ||| S:598 E:607 ||| NNS
-  ||| S:607 E:609 ||| :
is  ||| S:609 E:612 ||| VBZ
largely  ||| S:612 E:620 ||| RB
responsible  ||| S:620 E:632 ||| JJ
for  ||| S:632 E:636 ||| IN
regulating  ||| S:636 E:647 ||| VBG
plasma  ||| S:647 E:654 ||| NNS
[ ||| S:654 E:655 ||| -LRB-
HCO3- ||| S:655 E:660 ||| NNP
] ||| S:660 E:661 ||| -RRB-
.  ||| S:661 E:663 ||| .
In  ||| S:663 E:666 ||| IN
this  ||| S:666 E:671 ||| DT
review  ||| S:671 E:678 ||| NN
we  ||| S:678 E:681 ||| PRP
first  ||| S:681 E:687 ||| JJ
focus  ||| S:687 E:693 ||| NN
on  ||| S:693 E:696 ||| IN
the  ||| S:696 E:700 ||| DT
milestone  ||| S:700 E:710 ||| JJ
discoveries  ||| S:710 E:722 ||| NNS
over  ||| S:722 E:727 ||| IN
the  ||| S:727 E:731 ||| DT
past  ||| S:731 E:736 ||| JJ
50+  ||| S:736 E:740 ||| CD
years  ||| S:740 E:746 ||| NNS
that  ||| S:746 E:751 ||| WDT
define  ||| S:751 E:758 ||| VBZ
the  ||| S:758 E:762 ||| DT
mechanism  ||| S:762 E:772 ||| NN
and  ||| S:772 E:776 ||| CC
regulation  ||| S:776 E:787 ||| NN
of  ||| S:787 E:790 ||| IN
acid-base  ||| S:790 E:800 ||| JJ
transport  ||| S:800 E:810 ||| NN
by  ||| S:810 E:813 ||| IN
the  ||| S:813 E:817 ||| DT
proximal  ||| S:817 E:826 ||| JJ
tubule ||| S:826 E:832 ||| NN
.  ||| S:832 E:834 ||| .
Further  ||| S:834 E:842 ||| RBR
on  ||| S:842 E:845 ||| IN
in  ||| S:845 E:848 ||| IN
the  ||| S:848 E:852 ||| DT
review ||| S:852 E:858 ||| NN
,  ||| S:858 E:860 ||| ,
we  ||| S:860 E:863 ||| PRP
will  ||| S:863 E:868 ||| MD
summarize  ||| S:868 E:878 ||| VB
research  ||| S:878 E:887 ||| NN
still  ||| S:887 E:893 ||| RB
in  ||| S:893 E:896 ||| IN
progress  ||| S:896 E:905 ||| NN
from  ||| S:905 E:910 ||| IN
our  ||| S:910 E:914 ||| PRP$
laboratory ||| S:914 E:924 ||| NN
,  ||| S:924 E:926 ||| ,
work  ||| S:926 E:931 ||| NN
that  ||| S:931 E:936 ||| WDT
addresses  ||| S:936 E:946 ||| VBZ
the  ||| S:946 E:950 ||| DT
problem  ||| S:950 E:958 ||| NN
of  ||| S:958 E:961 ||| IN
how  ||| S:961 E:965 ||| WRB
the  ||| S:965 E:969 ||| DT
PT  ||| S:969 E:972 ||| NNP
is  ||| S:972 E:975 ||| VBZ
able  ||| S:975 E:980 ||| JJ
to  ||| S:980 E:983 ||| TO
finely  ||| S:983 E:990 ||| VB
adapt  ||| S:990 E:996 ||| VBN
to  ||| S:996 E:999 ||| TO
acid-base  ||| S:999 E:1009 ||| JJ
disturbances  ||| S:1009 E:1022 ||| NNS
by  ||| S:1022 E:1025 ||| IN
rapidly  ||| S:1025 E:1033 ||| RB
sensing  ||| S:1033 E:1041 ||| JJ
changes  ||| S:1041 E:1049 ||| NNS
in  ||| S:1049 E:1052 ||| IN
basolateral  ||| S:1052 E:1064 ||| JJ
levels  ||| S:1064 E:1071 ||| NNS
of  ||| S:1071 E:1074 ||| IN
HCO3-  ||| S:1074 E:1080 ||| NNP
and  ||| S:1080 E:1084 ||| CC
CO2  ||| S:1084 E:1088 ||| NNP
( ||| S:1088 E:1089 ||| -LRB-
but  ||| S:1089 E:1093 ||| CC
not  ||| S:1093 E:1097 ||| RB
pH ||| S:1097 E:1099 ||| JJ
) ||| S:1099 E:1100 ||| -RRB-
,  ||| S:1100 E:1102 ||| ,
and  ||| S:1102 E:1106 ||| CC
thereby  ||| S:1106 E:1114 ||| RB
to  ||| S:1114 E:1117 ||| TO
exert  ||| S:1117 E:1123 ||| VB
tight  ||| S:1123 E:1129 ||| JJ
control  ||| S:1129 E:1137 ||| NN
over  ||| S:1137 E:1142 ||| IN
the  ||| S:1142 E:1146 ||| DT
acid-base  ||| S:1146 E:1156 ||| JJ
composition  ||| S:1156 E:1168 ||| NN
of  ||| S:1168 E:1171 ||| IN
the  ||| S:1171 E:1175 ||| DT
blood  ||| S:1175 E:1181 ||| NN
plasma ||| S:1181 E:1187 ||| NN
.  ||| S:1187 E:1189 ||| .
